For many New Zealanders living with Obsessive Compulsive Disorder (OCD), the gap between diagnosis and effective treatment is a chasm. While the gold-standard approach—Exposure and Response Prevention (ERP)—exists, This proves often difficult to access and requires a prolonged time commitment that many cannot sustain. The arrival of the Bergen Four-Day OCD Treatment (B4DT) in Aotearoa represents a potential “circuit-breaker” for this population, condensing months of therapy into an intensive four-day window.
The urgency for such a model is underscored by the scale of the disorder. It is estimated that up to 100,000 New Zealanders live with OCD, yet only a minor fraction receive specialized care. In a pressured health system, most patients struggle to find clinicians trained in intensive ERP, often leaving them to manage debilitating rituals in isolation.
The weight of the ritual
The lived experience of severe OCD is often far removed from the sanitized depictions seen in popular media. For “Isabella,” a participant in an initial New Zealand trial, the disorder narrowed her world over eight years into a relentless cycle of fear. Her obsession centered on the belief that if she were not meticulously clean, she would be responsible for passing a disease to a loved one.
This responsibility became all-consuming, driving compulsions that took up hours of her day and reduced her sleep to just a few hours a night. Despite knowing her fears were not logical, the intensity of the anxiety remained absolute. After trying various medications and specialists without lasting success, Isabella participated in the B4DT trial in January.
Two months after the four-day intensive, Isabella describes a fundamental shift: “I’ve learned that just because I have the thoughts it doesn’t mean I have to act on them.”
Condensing the recovery process
Developed in Norway by psychologists Gerd Kvale and Bjarne Hansen, the B4DT method does not invent a new science; rather, it optimizes the delivery of ERP. Standard ERP involves gradually exposing a patient to their triggers while preventing the subsequent compulsive response. B4DT compresses this process into four consecutive days of intensive, supported exposure function in a group setting.
The goal is to assist patients “lean into” their anxiety rather than avoid it. Dr. Bjarne Hansen emphasizes that while the physical procedure can be paced, the intention must be absolute. Patients must make a decisive choice: act as if the situation is dangerous, or act as if it is not. There is no middle ground in the intention to recover.
Treatment Outcomes: International data indicates that approximately 90% of patients respond to the B4DT treatment. Long-term follow-ups show that 68% of patients remain in remission 12 months after treatment, with 69% still well at the four-year mark.
Beyond the clinical mechanics, Dr. Hansen advocates for a shift in how society views those with OCD. He argues that the field has over-medicalized the condition, viewing patients as “broken.” Instead, he views the traits that fuel OCD—such as an intense sense of responsibility and attention to detail—as strengths that have simply been mischanneled.
Bridging the access gap in Aotearoa
The treatment is being brought to New Zealand by Open Closed Doors, a charity founded by a collective of clinicians, health advocates, and families. The initiative has received critical support from the Kavli Trust, a Norwegian charity that is funding the training of New Zealand clinicians.
To establish a local workforce, five New Zealand psychologists traveled to Singapore for certification. These therapists are expected to return in early September 2025 to begin delivering the program. INTERNAL_LINK: OCD treatment options NZ
The initial rollout is strategically focused on 18-to-24-year-olds, prioritizing early intervention to prevent the disorder from causing decades of disability. While district health services are beginning to integrate the B4DT model, the charity notes that demand is expected to be high, and expanded access will depend on securing ongoing public or private funding. INTERNAL_LINK: Mental health funding Aotearoa
Frequently Asked Questions
- Who is eligible for the initial NZ offering? The primary focus is on young adults aged 18-24, though some exceptions may be considered.
- Is B4DT a replacement for medication? The source material describes it as a “circuit-breaker” intensive therapy based on ERP, but does not specify its use as a total replacement for medication; patients should consult their clinicians.
- How does it differ from standard therapy? Unlike traditional weekly sessions, B4DT is a four-day intensive group program designed to produce rapid results through concentrated exposure.
As the program moves from trial to broader implementation, the central challenge remains one of scale: how to move a specialized, intensive treatment from a small group of pioneers to the thousands of Kiwis still waiting for help.
How might the integration of intensive, short-term models like B4DT change the way public health systems approach severe anxiety and OCD?
